找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

新窗
投票 SCIE期刊CLINICAL THERAPEUTICS 2024/2025影响因子:3.207 (CLIN THER) (0149-2918). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citat  ...234
Total Citations:8387; 2023 JIF:3.207; JIFRank: 124/354 ; Rank-JIF: 124; Number-of-JIF:354; 5 Year JIF:3.161; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.2; Immediacy Index:1; Immediacy Index-dealt:1.135; 2023 JCI:0.73; JCI Rank: 154/354 ; Total Articles:83; JCI Quartile:Q2; JCI Percentile:56.64; Eigenfactor:0.006; Normalized Eigenfactor:1.341; Article Influence Score:0.862; JIF Percentile:65.1; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:135; % of Articles in Citable items:0.6148; Cited Half-Life:8.5; Citing Half-Life:6.1; % of OA Gold:0.2713; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, Unite
投票 SCIE期刊Chinese Medicine 2024/2025影响因子:5.355 (CHIN MED-UK) (1749-8546). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation  ...234
Total Citations:4170; 2023 JIF:5.355; JIFRank: 34/354 ; Rank-JIF: 34; Number-of-JIF:354; 5 Year JIF:5.524; 5 Year JIF Quartile:Q1; JIF Without Self Cites:5; Immediacy Index:0.9; Immediacy Index-dealt:0.978; 2023 JCI:1.32; JCI Rank: 40/354 ; Total Articles:115; JCI Quartile:Q1; JCI Percentile:88.84; Eigenfactor:0.004; Normalized Eigenfactor:0.797; Article Influence Score:0.827; JIF Percentile:90.5; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:157; % of Articles in Citable items:0.7325; Cited Half-Life:3.8; Citing Half-Life:5.5; % of OA Gold:1; Publisher name:KOREAN SOC BIOTECHNOLOGY & BIOENGINEERING; Publisher address:KOREAN SCIENCE TECHNOL
投票 SCIE期刊CNS Neuroscience & Therapeutics 2024/2025影响因子:4.862 (CNS NEUROSCI THER) (1755-5930). (PHARMACOLOGY & PHARMACY)(药理  ...234
Total Citations:7555; 2023 JIF:4.862; JIFRank: 50/354 ; Rank-JIF: 50; Number-of-JIF:354; 5 Year JIF:5.984; 5 Year JIF Quartile:Q1; JIF Without Self Cites:4.6; Immediacy Index:0.8; Immediacy Index-dealt:0.804; 2023 JCI:1.26; JCI Rank: 50/354 ; Total Articles:387; JCI Quartile:Q1; JCI Percentile:86.02; Eigenfactor:0.009; Normalized Eigenfactor:1.887; Article Influence Score:1.425; JIF Percentile:86; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:443; % of Articles in Citable items:0.8736; Cited Half-Life:4.8; Citing Half-Life:6.3; % of OA Gold:0.7778; Publisher name:ECOLE HAUTES ETUDES & SCI SOC, CENTRE RECHERCHES BRESIL CONTEMP; Publisher add
投票 SCIE期刊ACTA PHARMACOLOGICA SINICA 2024/2025影响因子:6.987 (ACTA PHARMACOL SIN) (1671-4083). (PHARMACOLOGY & PHARMACY)(药理学与药学  ...234
Total Citations:15928; 2023 JIF:6.987; JIFRank: 15/354 ; Rank-JIF: 15; Number-of-JIF:354; 5 Year JIF:7.643; 5 Year JIF Quartile:Q1; JIF Without Self Cites:6.8; Immediacy Index:1.1; Immediacy Index-dealt:1.118; 2023 JCI:1.43; JCI Rank: 28/354 ; Total Articles:142; JCI Quartile:Q1; JCI Percentile:92.23; Eigenfactor:0.013; Normalized Eigenfactor:2.849; Article Influence Score:1.473; JIF Percentile:95.9; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:156; % of Articles in Citable items:0.9103; Cited Half-Life:5.8; Citing Half-Life:6.1; % of OA Gold:0.1143; Publisher name:SPRINGER-VERLAG ITALIA SRL; Publisher address:VIA DECEMBRIO, 28, MILAN, ITA
投票 SCIE期刊CURRENT PHARMACEUTICAL DESIGN 2024/2025影响因子:2.626 (CURR PHARM DESIGN) (1381-6128). (PHARMACOLOGY & PHARMACY)(药理学与  ...234
Total Citations:19484; 2023 JIF:2.626; JIFRank: 173/354 ; Rank-JIF: 173; Number-of-JIF:354; 5 Year JIF:3.115; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.5; Immediacy Index:0.7; Immediacy Index-dealt:0.782; 2023 JCI:0.48; JCI Rank: 247/354 ; Total Articles:99; JCI Quartile:Q3; JCI Percentile:30.37; Eigenfactor:0.009; Normalized Eigenfactor:1.991; Article Influence Score:0.528; JIF Percentile:51.3; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:276; % of Articles in Citable items:0.3587; Cited Half-Life:8.4; Citing Half-Life:6.9; % of OA Gold:0.0134; Publisher name:ASSOC CHAMP PENAL-PENAL FIELD; Publisher address:ASSOC CHAMP PENAL-PENAL
投票 SCIE期刊HIV Research & Clinical Practice 2024/2025影响因子:1.742 (HIV RES CLIN PRACT) (2578-7489). (PHARMACOLOGY & PHARMACY)(  ...234
Total Citations:109; 2023 JIF:1.742; JIFRank: 251/354 ; Rank-JIF: 251; Number-of-JIF:354; 5 Year JIF:1.761; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.6; Immediacy Index:0.1; Immediacy Index-dealt:0.127; 2023 JCI:0.35; JCI Rank: 284/354 ; Total Articles:12; JCI Quartile:Q4; JCI Percentile:19.92; Eigenfactor:0; Normalized Eigenfactor:0.076; Article Influence Score:0.658; JIF Percentile:29.2; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:13; % of Articles in Citable items:0.9231; Cited Half-Life:2.9; Citing Half-Life:6.7; % of OA Gold:0.0652; Publisher name:RUSSIAN ACAD SCIENCES, STATE ACAD UNIV HUMANITIES (GAUGN); Publisher address:Len
投票 SCIE期刊PHARMACOLOGICAL REVIEWS 2024/2025影响因子:19.362 (PHARMACOL REV) (0031-6997). (PHARMACOLOGY & PHARMACY)(药理学与药学)Scienc  ...234
Total Citations:12604; 2023 JIF:19.362; JIFRank: 2/354 ; Rank-JIF: 2; Number-of-JIF:354; 5 Year JIF:22.193; 5 Year JIF Quartile:Q1; JIF Without Self Cites:19.3; Immediacy Index:4.9; Immediacy Index-dealt:4.931; 2023 JCI:2.89; JCI Rank: 4/354 ; Total Articles:0; JCI Quartile:Q1; JCI Percentile:99.01; Eigenfactor:0.008; Normalized Eigenfactor:1.743; Article Influence Score:6.592; JIF Percentile:99.6; JIF Quartile:Q1; AIS Quartile:Q1; Citable Items:36; % of Articles in Citable items:0; Cited Half-Life:11.3; Citing Half-Life:9.9; % of OA Gold:0.4495; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊Drug Metabolism and Pharmacokinetics 2024/2025影响因子:2.737 (DRUG METAB PHARMACOK) (1347-4367). (PHARMACOLOGY & PHAR  ...234
Total Citations:1987; 2023 JIF:2.737; JIFRank: 167/354 ; Rank-JIF: 167; Number-of-JIF:354; 5 Year JIF:2.413; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.5; Immediacy Index:0.6; Immediacy Index-dealt:0.665; 2023 JCI:0.64; JCI Rank: 183/354 ; Total Articles:39; JCI Quartile:Q3; JCI Percentile:48.45; Eigenfactor:0.001; Normalized Eigenfactor:0.265; Article Influence Score:0.545; JIF Percentile:53; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:40; % of Articles in Citable items:0.975; Cited Half-Life:9.9; Citing Half-Life:11.3; % of OA Gold:0.3649; Publisher name:PURDUE UNIV PRESS; Publisher address:1207 SOUTH CAMPUS COURTS-E, W LAFAYETTE,
投票 SCIE期刊INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY 2024/2025影响因子:3.140 (INT J IMMUNOPATH PH) (0394-6320).  ...234
Total Citations:3009; 2023 JIF:3.140; JIFRank: 136/354 ; Rank-JIF: 136; Number-of-JIF:354; 5 Year JIF:3.151; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3; Immediacy Index:0.7; Immediacy Index-dealt:0.757; 2023 JCI:0.76; JCI Rank: 136/354 ; Total Articles:71; JCI Quartile:Q2; JCI Percentile:53.98; Eigenfactor:0.002; Normalized Eigenfactor:0.397; Article Influence Score:0.614; JIF Percentile:69.9; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:77; % of Articles in Citable items:0.9221; Cited Half-Life:8.1; Citing Half-Life:6; % of OA Gold:0.9342; Publisher name:AMER PSYCHOLOGICAL ASSOC; Publisher address:750 FIRST ST NE, WASHINGTON, USA, D
投票 SCIE期刊Expert Opinion On Drug Safety 2024/2025影响因子:3.129 (EXPERT OPIN DRUG SAF) (1474-0338). (PHARMACOLOGY & PHARMACY)(药  ...234
Total Citations:4898; 2023 JIF:3.129; JIFRank: 136/354 ; Rank-JIF: 136; Number-of-JIF:354; 5 Year JIF:3.691; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.9; Immediacy Index:0.6; Immediacy Index-dealt:0.659; 2023 JCI:0.62; JCI Rank: 192/354 ; Total Articles:104; JCI Quartile:Q3; JCI Percentile:45.9; Eigenfactor:0.005; Normalized Eigenfactor:1.011; Article Influence Score:0.958; JIF Percentile:61.7; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:155; % of Articles in Citable items:0.671; Cited Half-Life:6.8; Citing Half-Life:5.7; % of OA Gold:0.1418; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE
投票 SCIE期刊PHARMACOLOGY 2024/2025影响因子:2.996 (PHARMACOLOGY) (0031-7012). (PHARMACOLOGY & PHARMACY)(药理学与药学)Science Citation In  ...234
Total Citations:2891; 2023 JIF:2.996; JIFRank: 147/354 ; Rank-JIF: 147; Number-of-JIF:354; 5 Year JIF:2.535; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.8; Immediacy Index:0.7; Immediacy Index-dealt:0.767; 2023 JCI:0.74; JCI Rank: 149/354 ; Total Articles:39; JCI Quartile:Q2; JCI Percentile:58.05; Eigenfactor:0.002; Normalized Eigenfactor:0.351; Article Influence Score:0.503; JIF Percentile:58.6; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:47; % of Articles in Citable items:0.8298; Cited Half-Life:10.3; Citing Half-Life:7.9; % of OA Gold:0.2116; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊Chinese Journal of Natural Medicines 2024/2025影响因子:4.159 (CHIN J NAT MEDICINES) (2095-6975). (PHARMACOLOGY & PHAR  ...234
Total Citations:3550; 2023 JIF:4.159; JIFRank: 82/354 ; Rank-JIF: 82; Number-of-JIF:354; 5 Year JIF:3.704; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.7; Immediacy Index:0.8; Immediacy Index-dealt:0.857; 2023 JCI:1.08; JCI Rank: 71/354 ; Total Articles:68; JCI Quartile:Q1; JCI Percentile:80.08; Eigenfactor:0.002; Normalized Eigenfactor:0.506; Article Influence Score:0.572; JIF Percentile:77; JIF Quartile:Q1; AIS Quartile:Q3; Citable Items:78; % of Articles in Citable items:0.8718; Cited Half-Life:5.6; Citing Half-Life:5.8; % of OA Gold:0; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABINGDON, Engla
投票 SCIE期刊JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS 2024/2025影响因子:2.569 (J CARDIOVASC PHARM T) (1074-2484). (  ...234
Total Citations:1484; 2023 JIF:2.569; JIFRank: 180/354 ; Rank-JIF: 180; Number-of-JIF:354; 5 Year JIF:2.342; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.4; Immediacy Index:0.6; Immediacy Index-dealt:0.682; 2023 JCI:0.56; JCI Rank: 215/354 ; Total Articles:19; JCI Quartile:Q3; JCI Percentile:39.41; Eigenfactor:0.001; Normalized Eigenfactor:0.28; Article Influence Score:0.553; JIF Percentile:49.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:27; % of Articles in Citable items:0.7037; Cited Half-Life:6.7; Citing Half-Life:6.4; % of OA Gold:0.5882; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊CPT-Pharmacometrics & Systems Pharmacology 2024/2025影响因子:3.102 (CPT-PHARMACOMET SYST) (2163-8306). (PHARMACOLOGY  ...234
Total Citations:3126; 2023 JIF:3.102; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:3.645; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.6; Immediacy Index:0.7; Immediacy Index-dealt:0.712; 2023 JCI:0.95; JCI Rank: 92/354 ; Total Articles:161; JCI Quartile:Q2; JCI Percentile:74.15; Eigenfactor:0.004; Normalized Eigenfactor:0.908; Article Influence Score:1.044; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:170; % of Articles in Citable items:0.9471; Cited Half-Life:5; Citing Half-Life:7.3; % of OA Gold:0.7798; Publisher name:SPRINGER; Publisher address:VAN GODEWIJCKSTRAAT 30, DORDRECHT, NETHERLANDS,
投票 SCIE期刊JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS 2024/2025影响因子:1.963 (J OCUL PHARMACOL TH) (1080-7683). (PHARMACOL  ...234
Total Citations:2769; 2023 JIF:1.963; JIFRank: 231/354 ; Rank-JIF: 231; Number-of-JIF:354; 5 Year JIF:3.461; 5 Year JIF Quartile:Q2; JIF Without Self Cites:1.8; Immediacy Index:0.4; Immediacy Index-dealt:0.405; 2023 JCI:0.84; JCI Rank: 116/354 ; Total Articles:63; JCI Quartile:Q2; JCI Percentile:67.37; Eigenfactor:0.002; Normalized Eigenfactor:0.372; Article Influence Score:0.758; JIF Percentile:34.9; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:69; % of Articles in Citable items:0.913; Cited Half-Life:8.6; Citing Half-Life:8; % of OA Gold:0.1505; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, M
投票 SCIE期刊Environmental Toxicology and Pharmacology 2024/2025影响因子:4.278 (ENVIRON TOXICOL PHAR) (1382-6689). (PHARMACOLOGY &  ...234
Total Citations:9805; 2023 JIF:4.278; JIFRank: 75/354 ; Rank-JIF: 75; Number-of-JIF:354; 5 Year JIF:4.436; 5 Year JIF Quartile:Q1; JIF Without Self Cites:3.9; Immediacy Index:1.1; Immediacy Index-dealt:1.186; 2023 JCI:1.05; JCI Rank: 76/354 ; Total Articles:220; JCI Quartile:Q1; JCI Percentile:78.67; Eigenfactor:0.005; Normalized Eigenfactor:1.2; Article Influence Score:0.753; JIF Percentile:79; JIF Quartile:Q1; AIS Quartile:Q2; Citable Items:224; % of Articles in Citable items:0.9821; Cited Half-Life:7; Citing Half-Life:6.8; % of OA Gold:0.1748; Publisher name:SPRINGER INT PUBL AG; Publisher address:GEWERBESTRASSE 11, CHAM, SWITZERLAND, CH-6
投票 SCIE期刊AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION 2024/2025影响因子:3.834 (AM J PHARM EDUC) (0002-9459). (PHARMACOLOGY & P  ...234
Total Citations:6433; 2023 JIF:3.834; JIFRank: 89/354 ; Rank-JIF: 89; Number-of-JIF:354; 5 Year JIF:3.811; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.3; Immediacy Index:0.8; Immediacy Index-dealt:0.822; 2023 JCI:0.97; JCI Rank: 88/354 ; Total Articles:168; JCI Quartile:Q1; JCI Percentile:75.28; Eigenfactor:0.004; Normalized Eigenfactor:0.862; Article Influence Score:0.736; JIF Percentile:75; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:198; % of Articles in Citable items:0.8485; Cited Half-Life:7.3; Citing Half-Life:6.9; % of OA Gold:0.7927; Publisher name:CZECH ACADEMY AGRICULTURAL SCIENCES; Publisher address:TESNOV 17, PRAGUE, CZEC
投票 SCIE期刊International Journal of Pharmacology 2024/2025影响因子:0.343 (INT J PHARMACOL) (1811-7775). (PHARMACOLOGY & PHARMACY  ...234
Total Citations:1034; 2023 JIF:0.343; JIFRank: 344/354 ; Rank-JIF: 344; Number-of-JIF:354; 5 Year JIF:0.416; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:0.1; Immediacy Index-dealt:0.193; 2023 JCI:0.12; JCI Rank: 336/354 ; Total Articles:94; JCI Quartile:Q4; JCI Percentile:5.23; Eigenfactor:0; Normalized Eigenfactor:0.055; Article Influence Score:0.055; JIF Percentile:3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:95; % of Articles in Citable items:0.9895; Cited Half-Life:8.3; Citing Half-Life:6.7; % of OA Gold:0; Publisher name:ACADEMIC PRESS INC ELSEVIER SCIENCE; Publisher address:525 B ST, STE 1900, SAN DIEGO, US
投票 SCIE期刊REGULATORY TOXICOLOGY AND PHARMACOLOGY 2024/2025影响因子:3.154 (REGUL TOXICOL PHARM) (0273-2300). (PHARMACOLOGY & PHA  ...234
Total Citations:9087; 2023 JIF:3.154; JIFRank: 136/354 ; Rank-JIF: 136; Number-of-JIF:354; 5 Year JIF:3.174; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.7; Immediacy Index:0.9; Immediacy Index-dealt:0.921; 2023 JCI:1.16; JCI Rank: 59/354 ; Total Articles:135; JCI Quartile:Q1; JCI Percentile:83.47; Eigenfactor:0.005; Normalized Eigenfactor:1.041; Article Influence Score:0.584; JIF Percentile:61.7; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:143; % of Articles in Citable items:0.9441; Cited Half-Life:7.9; Citing Half-Life:8; % of OA Gold:0.4809; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 SCIE期刊PHARMACEUTICAL RESEARCH 2024/2025影响因子:3.551 (PHARM RES-DORDR) (0724-8741). (PHARMACOLOGY & PHARMACY)(药理学与药学)Scien  ...234
Total Citations:20070; 2023 JIF:3.551; JIFRank: 100/354 ; Rank-JIF: 100; Number-of-JIF:354; 5 Year JIF:3.881; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.4; Immediacy Index:0.8; Immediacy Index-dealt:0.822; 2023 JCI:0.82; JCI Rank: 123/354 ; Total Articles:164; JCI Quartile:Q2; JCI Percentile:65.4; Eigenfactor:0.006; Normalized Eigenfactor:1.395; Article Influence Score:0.708; JIF Percentile:71.9; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:182; % of Articles in Citable items:0.9011; Cited Half-Life:13; Citing Half-Life:9.1; % of OA Gold:0.2217; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUAR
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-1 10:42
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块